Global Advanced Drug Delivery Systems 麻豆原创 Research Report 2023

Publication ID:

PB502234709

Publication Date:

February 7, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Advanced drug delivery systems are the improved methods for delivering the drug molecule to the targeted site in a more controlled manner. These methods are developed in order to improve the efficacy ratio of the currently available drugs. Delivering drug at the controlled rate, slow and targeted delivery for onsite drug release and absorption are the basis for the development of advanced drug delivery systems. Furthermore, the development of improved methods of drug delivery is preferred these days over the search for novel molecules. There are various dosage forms available by which a drug substance can be incorporated for efficacious delivery. Advancements in biotechnology and nanotechnology have significantly boosted the development of novel drug delivery approaches. Various interdisciplinary studies in the field of polymer science, pharmaceuticals, organic chemistry and molecular biology are required for the development of advanced drug delivery systems. The drug delivery system comprise of drug formulation, dosage form and mechanism of release. These advanced delivery systems have the potential of overcoming one of the major problem faced by the pharmaceutical industry for the onsite drug efficacy. Development of advanced drug delivery systems needs into consideration several factors such as pharmacodynamics, drug toxicity, immunogenicity, bio compatibility, pharmacokinetics as well as drug efficacy.
Highlights
The global Advanced Drug Delivery Systems market was valued at US$ 188960 million in 2022 and is anticipated to reach US$ 223010 million by 2029, witnessing a CAGR of 2.8% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Various advantages of advanced drug delivery systems over the conventional delivery systems such as on site action, reduce dosing amount, increased drug efficacy, therapeutic success rate etc. support its market growth. In addition, increasing clinical research activities in the development of more advanced drug delivery systems would also be fuelling the market growth. Certain technical limitations in the development of methods, stringent regulations, high pricing for the advanced products, non-availability in the low income countries are some of the factors limiting the market growth of global advanced drug delivery systems.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Advanced Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Advanced Drug Delivery Systems.
The Advanced Drug Delivery Systems market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Advanced Drug Delivery Systems market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Advanced Drug Delivery Systems companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
NeXstar Pharmaceuticals
West Pharmaceutical Services
AstraZeneca
Sequus Pharmaceuticals
3M
Novartis International
Segment by Type
Oral Drug Delivery
Pulmonary Drug Delivery
Transdermal Drug Delivery
Parenteral Drug Delivery
Segment by Application
Hospitals
Specialized Clinics
Clinical Research & Development Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Advanced Drug Delivery Systems companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Advanced Drug Delivery Systems 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Oral Drug Delivery
1.2.3 Pulmonary Drug Delivery
1.2.4 Transdermal Drug Delivery
1.2.5 Parenteral Drug Delivery
1.3 麻豆原创 by Application
1.3.1 Global Advanced Drug Delivery Systems 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Specialized Clinics
1.3.4 Clinical Research & Development Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Advanced Drug Delivery Systems 麻豆原创 Perspective (2018-2029)
2.2 Advanced Drug Delivery Systems Growth Trends by Region
2.2.1 Global Advanced Drug Delivery Systems 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Advanced Drug Delivery Systems Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Advanced Drug Delivery Systems Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Advanced Drug Delivery Systems 麻豆原创 Dynamics
2.3.1 Advanced Drug Delivery Systems Industry Trends
2.3.2 Advanced Drug Delivery Systems 麻豆原创 Drivers
2.3.3 Advanced Drug Delivery Systems 麻豆原创 Challenges
2.3.4 Advanced Drug Delivery Systems 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Advanced Drug Delivery Systems Players by Revenue
3.1.1 Global Top Advanced Drug Delivery Systems Players by Revenue (2018-2023)
3.1.2 Global Advanced Drug Delivery Systems Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Advanced Drug Delivery Systems 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Advanced Drug Delivery Systems Revenue
3.4 Global Advanced Drug Delivery Systems 麻豆原创 Concentration Ratio
3.4.1 Global Advanced Drug Delivery Systems 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Advanced Drug Delivery Systems Revenue in 2022
3.5 Advanced Drug Delivery Systems Key Players Head office and Area Served
3.6 Key Players Advanced Drug Delivery Systems Product Solution and Service
3.7 Date of Enter into Advanced Drug Delivery Systems 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Advanced Drug Delivery Systems Breakdown Data by Type
4.1 Global Advanced Drug Delivery Systems Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Advanced Drug Delivery Systems Forecasted 麻豆原创 Size by Type (2024-2029)
5 Advanced Drug Delivery Systems Breakdown Data by Application
5.1 Global Advanced Drug Delivery Systems Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Advanced Drug Delivery Systems Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Advanced Drug Delivery Systems 麻豆原创 Size (2018-2029)
6.2 North America Advanced Drug Delivery Systems 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Advanced Drug Delivery Systems 麻豆原创 Size by Country (2018-2023)
6.4 North America Advanced Drug Delivery Systems 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Advanced Drug Delivery Systems 麻豆原创 Size (2018-2029)
7.2 Europe Advanced Drug Delivery Systems 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Advanced Drug Delivery Systems 麻豆原创 Size by Country (2018-2023)
7.4 Europe Advanced Drug Delivery Systems 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Advanced Drug Delivery Systems 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Advanced Drug Delivery Systems 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Advanced Drug Delivery Systems 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Advanced Drug Delivery Systems 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Advanced Drug Delivery Systems 麻豆原创 Size (2018-2029)
9.2 Latin America Advanced Drug Delivery Systems 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Advanced Drug Delivery Systems 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Advanced Drug Delivery Systems 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Advanced Drug Delivery Systems 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Advanced Drug Delivery Systems 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Advanced Drug Delivery Systems 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Advanced Drug Delivery Systems 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 NeXstar Pharmaceuticals
11.1.1 NeXstar Pharmaceuticals Company Detail
11.1.2 NeXstar Pharmaceuticals Business Overview
11.1.3 NeXstar Pharmaceuticals Advanced Drug Delivery Systems Introduction
11.1.4 NeXstar Pharmaceuticals Revenue in Advanced Drug Delivery Systems Business (2018-2023)
11.1.5 NeXstar Pharmaceuticals Recent Development
11.2 West Pharmaceutical Services
11.2.1 West Pharmaceutical Services Company Detail
11.2.2 West Pharmaceutical Services Business Overview
11.2.3 West Pharmaceutical Services Advanced Drug Delivery Systems Introduction
11.2.4 West Pharmaceutical Services Revenue in Advanced Drug Delivery Systems Business (2018-2023)
11.2.5 West Pharmaceutical Services Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Detail
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Advanced Drug Delivery Systems Introduction
11.3.4 AstraZeneca Revenue in Advanced Drug Delivery Systems Business (2018-2023)
11.3.5 AstraZeneca Recent Development
11.4 Sequus Pharmaceuticals
11.4.1 Sequus Pharmaceuticals Company Detail
11.4.2 Sequus Pharmaceuticals Business Overview
11.4.3 Sequus Pharmaceuticals Advanced Drug Delivery Systems Introduction
11.4.4 Sequus Pharmaceuticals Revenue in Advanced Drug Delivery Systems Business (2018-2023)
11.4.5 Sequus Pharmaceuticals Recent Development
11.5 3M
11.5.1 3M Company Detail
11.5.2 3M Business Overview
11.5.3 3M Advanced Drug Delivery Systems Introduction
11.5.4 3M Revenue in Advanced Drug Delivery Systems Business (2018-2023)
11.5.5 3M Recent Development
11.6 Novartis International
11.6.1 Novartis International Company Detail
11.6.2 Novartis International Business Overview
11.6.3 Novartis International Advanced Drug Delivery Systems Introduction
11.6.4 Novartis International Revenue in Advanced Drug Delivery Systems Business (2018-2023)
11.6.5 Novartis International Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

NeXstar Pharmaceuticals
West Pharmaceutical Services
AstraZeneca
Sequus Pharmaceuticals
3M
Novartis International

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.